| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.83M | 19.83M | 27.88M | 19.25M | 39.33M | 27.88M |
| Gross Profit | -2.99M | -2.99M | 7.83M | -7.18M | -6.77M | -342.89K |
| EBITDA | -6.13M | -6.13M | 5.04M | -9.06M | -11.87M | -4.08M |
| Net Income | -6.55M | -6.55M | 4.77M | -10.02M | -10.89M | -3.21M |
Balance Sheet | ||||||
| Total Assets | 48.30M | 48.30M | 28.05M | 17.92M | 24.10M | 28.77M |
| Cash, Cash Equivalents and Short-Term Investments | 10.66M | 10.66M | 8.84M | 1.00M | 3.12M | 13.07M |
| Total Debt | 31.31M | 31.31M | 9.07M | 7.62M | 2.63M | 2.78M |
| Total Liabilities | 40.45M | 40.45M | 19.28M | 15.75M | 12.21M | 12.50M |
| Stockholders Equity | 7.85M | 7.85M | 8.77M | 2.17M | 11.88M | 16.27M |
Cash Flow | ||||||
| Free Cash Flow | -21.50M | -21.50M | 6.89M | -6.80M | -15.21M | -2.59M |
| Operating Cash Flow | -5.66M | -5.66M | 7.24M | -5.36M | -11.77M | 156.59K |
| Investing Cash Flow | -15.08M | -15.08M | -3.92M | -1.44M | -3.44M | -4.49M |
| Financing Cash Flow | 23.33M | 23.33M | 915.22K | 4.68M | 5.26M | 14.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | AU$27.00M | 19.41 | 14.11% | ― | -11.85% | 6.25% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
49 Neutral | AU$29.76M | -11.41 | -11.34% | ― | -8.52% | 13.51% | |
48 Neutral | AU$10.40M | -2.07 | -47.12% | ― | ― | -15.24% | |
47 Neutral | AU$17.35M | -4.92 | -38.32% | ― | 2.69% | -273.87% | |
40 Underperform | AU$20.93M | -2.33 | -129.44% | ― | -29.97% | -284.16% | |
34 Underperform | AU$14.63M | -0.84 | -84.32% | ― | ― | 91.54% |
Delorean Corporation has confirmed that its proposed Horsley Park Bioenergy plant in New South Wales will not proceed after partner Brickworks chose not to move toward a final investment decision on the jointly developed project. In response, Delorean plans to redirect its efforts to other project opportunities in NSW, advance its VIC1 project into construction, and continue progressing construction of its wholly owned SA1 facility, signalling a reallocation of capital and management focus that may reshape its development pipeline but underlines its broader commitment to expanding bioenergy capacity across multiple states.
The most recent analyst rating on (AU:DEL) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.
Delorean Corporation Limited, a company listed on the Australian Securities Exchange, held its Annual General Meeting on 28 November 2025 in West Perth, Western Australia. During the meeting, all resolutions were decided by a poll, and the outcomes were favorable, with all proposed resolutions being carried. This includes the adoption of the remuneration report, the re-election of directors, ratification of prior issue of options, approval of a 7.1A mandate, and the appointment of an auditor. These results indicate strong shareholder support for the company’s current management and strategic direction.
The most recent analyst rating on (AU:DEL) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.
Delorean Corporation Ltd presented at its Annual General Meeting, emphasizing its role in catalyzing Australia’s bioenergy sector. The presentation highlighted the company’s strategic focus on renewable energy and its potential impact on the industry, although it cautioned that the information provided was not a basis for investment decisions.
The most recent analyst rating on (AU:DEL) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.
Delorean Corporation Ltd has reached a significant milestone with the completion of its largest construction contract, the Lilydale bioenergy facility, and is progressing with its first fully-owned project in South Australia. The company is expanding its build/own/operate clean energy infrastructure, with projects in New South Wales and Victoria, and aims to generate diverse revenue streams from these assets. Delorean’s strategic collaboration with Paper Australia Pty Ltd highlights its commitment to expanding its portfolio, while maintaining a balanced financial strategy through debt management and grant funding.
The most recent analyst rating on (AU:DEL) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.
Delorean Corporation Limited has released its 2025 ESG report, emphasizing its commitment to Environmental, Social, and Governance (ESG) principles as a core component of its operations and success. The report outlines the company’s sustainability objectives, impact approach, and alignment with Australian and global sustainability standards. By integrating ESG strategies, Delorean aims to enhance its role in the global energy transition, benefiting stakeholders and reinforcing its market positioning.
Delorean Corporation Limited has made significant progress in its project portfolio for Q1 FY2026, achieving key milestones such as completing a $2.7 million ARENA milestone for the SA1 project and practical completion of the Yarra Valley Water project. The company has secured a $14.5 million loan from National Australia Bank to refinance existing debt and expand its Build-Own-Operate portfolio, alongside securing long-term revenue contracts for biomethane and liquid CO₂. Delorean is well-positioned to benefit from Australia’s increasing focus on renewable gas and decarbonization, supported by recent regulatory reforms and government initiatives.